BIRC5 and ovarian cancer: Furthermore, not only did inhibition of LSD1 in ovarian cancer cells, either pharmacologically or genetically, reduce the viability of ovarian cancer cells [31,33], LSD1 knockdown resulted in reduced expression of survivin [33].